Amarin Corp. Plc (AMRN)
13.70
-0.14
(-1.05%)
USD |
NASDAQ |
Sep 02, 16:00
13.70
0.00 (0.00%)
After-Hours: 18:50
Amarin Cash and Short Term Investments (Quarterly) : 314.85M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 314.85M |
| March 31, 2026 | 308.02M |
| December 31, 2025 | 302.79M |
| September 30, 2025 | 286.89M |
| June 30, 2025 | 299.00M |
| March 31, 2025 | 282.09M |
| December 31, 2024 | 294.52M |
| September 30, 2024 | 306.26M |
| June 30, 2024 | 307.19M |
| March 31, 2024 | 308.70M |
| December 31, 2023 | 321.18M |
| September 30, 2023 | 321.19M |
| June 30, 2023 | 313.44M |
| March 31, 2023 | 304.89M |
| December 31, 2022 | 309.88M |
| September 30, 2022 | 307.62M |
| June 30, 2022 | 317.15M |
| March 31, 2022 | 366.48M |
| December 31, 2021 | 458.05M |
| September 30, 2021 | 483.06M |
| June 30, 2021 | 512.84M |
| March 31, 2021 | 518.65M |
| December 31, 2020 | 504.85M |
| September 30, 2020 | 565.78M |
| June 30, 2020 | 554.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 546.14M |
| December 31, 2019 | 648.50M |
| September 30, 2019 | 677.11M |
| June 30, 2019 | 223.27M |
| March 31, 2019 | 212.59M |
| December 31, 2018 | 250.73M |
| September 30, 2018 | 82.49M |
| June 30, 2018 | 102.86M |
| March 31, 2018 | 129.65M |
| December 31, 2017 | 74.24M |
| September 30, 2017 | 79.69M |
| June 30, 2017 | 86.01M |
| March 31, 2017 | 96.77M |
| December 31, 2016 | 99.89M |
| September 30, 2016 | 118.26M |
| June 30, 2016 | 73.09M |
| March 31, 2016 | 81.96M |
| December 31, 2015 | 107.56M |
| September 30, 2015 | 119.58M |
| June 30, 2015 | 136.65M |
| March 31, 2015 | 161.80M |
| December 31, 2014 | 120.14M |
| September 30, 2014 | 132.73M |
| June 30, 2014 | 151.13M |
| March 31, 2014 | 164.88M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 389.80M |
| Alkermes Plc | 656.58M |
| Cellectis SA | 166.85M |
| Akari Therapeutics Plc | 7.754M |
| Liquidia Corp. | 284.18M |